Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD

This study has been terminated.

Sponsor:

Information provided by:

Astex Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00032773

First received: April 2, 2002

Last updated: October 12, 2009

Last verified: June 2005

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given